![]() ![]() Marijuana use during pregnancy and breast-feeding may pose potential harms. ![]() ![]() There is limited information on the side effects of using this product, and there may be associated health risks. Please Consume Responsibly Adult-Use: This product has not been analyzed or approved by the Food and Drug Administration (FDA). Medical marihuana is for use only by registered qualifying patients or registered primary caregivers. Always consult your primary care physician or other healthcare provider prior to using medical marihuana products for treatment of a medical condition. The information provided is meant to encourage medical marihuana education, not replace direct patient-healthcare professional relationships. Website content is not intended as medical advice. Medical cannabis products are for use only by a certified patient. Do not operate a vehicle or machinery under the influence of marijuana. Marijuana is not approved by the FDA to treat, cure, or prevent any disease. Marijuana use during pregnancy or breastfeeding poses potential harms. Marijuana is for use by qualified patients only. Always consult your primary care physician or other healthcare provider prior to using cannabis products for treatment of a medical condition. The information provided is meant to encourage cannabis education, not replace direct patient-healthcare professional relationships. "I think people have incentive to get the the dispensaries turned over to adult use.Website content is not intended as medical advice. "I think you're gonna see a ramp up quickly," Miles says. Still, Miles and Bayern agree that while they appreciate the head start, bringing in more businesses can only help build a robust market in New Jersey that benefits all involved: More dispensaries of all shapes and sizes across the state could attract more customers to the legal cannabis market.Ĭultivators like Curaleaf and Verano could even bring in additional revenue by supplying products to their dispensaries' smaller competitors. Companies like Curaleaf and Verano will likely have a huge head start establishing a foothold in what's expected to become a multibillion-dollar market. The approval timeline for those newer and smaller companies – including businesses run by people of color and others adversely affected by the war on drugs, per the state's own diversity goals – is currently unclear. But that's essentially the idea: The seven multi-state companies that launch recreational sales in New Jersey on Thursday can establish the market, while newer and smaller businesses spend the next several months building up supply and hiring staff. Miles says most cannabis companies originally prepared for New Jersey's recreational sales to begin in August 2021, and state's months of delays have afforded everyone even more time to stock up on supply.īayern acknowledges that the "limited number" of dispensaries will probably create a bottleneck for customers. That would be a problem: Empty shelves in dispensaries could send customers back to the illicit market, while making the rollout of recreational sales appear ill-planned or even mismanaged.ĭispensary owners predictably say they're ready. In fact, Bayern and Miles both say, state officials have been concerned for months that dispensaries might not have enough supply to meet consumer demand from the get-go. New Jersey's launch date of April 21 is very intentional: State regulators expressed concern that kicking off the recreational market on 4/20 would overwhelm dispensaries with new customers on the market's first day.
0 Comments
Leave a Reply. |